Resting-state brain activation correlates with short-time antidepressant treatment outcome in drug-naïve patients with major depressive disorder

Journal of International Medical Research

Volumn 42, Issue 4, 2014, Pages 966-975

  Wang, Li Juan ^a,b   Kuang, Wei Hong ^a   Xu, Jia Jun ^a   Lei, Du ^a   Yang, Yan Chun ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

amplitude of low frequency fluctuations; functional magnetic resonance imaging; Major depressive disorder; treatment outcome

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; DISEASE DURATION; EARLY INTERVENTION; ELECTROENCEPHALOGRAM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; LINGUAL GYRUS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; RESTING STATE NETWORK; SHORT COURSE THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE; DEPRESSIVE DISORDER, MAJOR; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PHYSIOLOGY; PROCEDURES;

ADULT; ANTIDEPRESSIVE AGENTS; CEREBELLUM; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING; OCCIPITAL LOBE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84904603621     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060514533524     Document Type: Article

References (46)

1. Lopez AD,Mathers CD,Ezzati M,et al.Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.Lancet. 2006;367:1747-1757.
2. Stimpson N,Agrawal N,Lewis G.Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression systematic review.Br J Psychiatry. 2002;181:284-294.
3. Lam RW.Onset, time course and trajectories of improvement with antidepressants.Eur Neuropsychopharmacol. 2012;22:S492-S498.
4. Szegedi A,Jansen WT,van Willigenburg AP,et al.Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients.J Clin Psychiatry. 2009;70:344-353.
5. Kim JM,Kim SY,Stewart R,et al.Improvement within 2 weeks and later treatment outcomes in patients with depressive disorders: the CRESCEND study.J Affect Disord. 2011;129:183-190.
6. Henkel V,Seemüller F,Obermeier M,et al.Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.J Affect Disord. 2009;115:439-449.
7. Dougherty DD,Rauch SL.Brain correlates of antidepressant treatment outcome from neuroimaging studies in depression.Psychiatr Clin North Am. 2007;30:91-103.
8. Fu CH,Steiner H,Costafreda SG.Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies.Neurobiol Dis. 2013;52:75-83.
9. Zang YF,He Y,Zhu CZ,et al.Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI.Brain Dev. 2007;29:83-91.
10. Biswal B,Yetkin FZ,Haughton VM,et al.Functional connectivity in the motor cortex of resting human brain using echo-planar MRI.Magn Reson Med. 1995;34:537-541.
11. Wang L,Dai W,Su Y,et al.Amplitude of low-frequency oscillations in first-episode, treatment-naive patients with major depressive disorder: a resting-state functional MRI study.PloS One. 2012;7:e48658-e48658.
12. Liu CH,Li F,Li SF,et al.Abnormal baseline brain activity in bipolar depression: a resting state functional magnetic resonance imaging study.Psychiatry Res. 2012;203:175-179.
13. Huang XQ,Lui S,Deng W,et al.Localization of cerebral functional deficits in treatment-naive, first-episode schizophrenia using resting-state fMRI.Neuroimage. 2010;49:2901-2906.
14. Guo WB,Liu F,Xue ZM,et al.Alterations of the amplitude of low-frequency fluctuations in treatment-resistant and treatment-response depression: a resting-state fMRI study.Prog Neuropsychopharmacol Biol Psychiatry. 2012;37:153-160.
15. Guo WB,Liu F,Chen JD,et al.Abnormal neural activity of brain regions in treatment-resistant and treatment-sensitive major depressive disorder: a resting-state fMRI study.J Psychiatr Res. 2012;46:1366-1373.
16. First MB,Spitzer RL,Gibbon M, et alStructured clinical interview for DSM-IV axis I disorders - clinician version (SCID-CV). Washington, DC: American Psychiatric Association; 1997:.
17. Annett M.A classification of hand preference by association analysis.Br J Psychol. 1970;61:303-321.
18. Hamilton M.Development of a rating scale for primary depressive illness.Br J Soc Clin Psychol. 1967;6:278-296.
19. Chao-Gan Y,Yu-Feng Z.DPARSF: a MATLAB toolbox for "Pipeline" data analysis of resting-state fMRI.Front Syst Neurosci. 2010;4:13-13.
20. Song XW,Dong ZY,Long XY,et al.REST: a toolkit for resting-state functional magnetic resonance imaging data processing.PloS One. 2011;6:e25031-e25031.
21. Cook IA,Leuchter AF,Morgan ML,et al.Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study.J Psychiatr Res. 2005;39:461-466.
22. Rush AJ,Trivedi MH,Stewart JW,et al.Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.Am J Psychiatry. 2011;168:689-701.
23. Stuhrmann A,Suslow T,Dannlowski U.Facial emotion processing in major depression: a systematic review of neuroimaging findings.Biol Mood Anxiety Disord. 2011;1:10-10.
24. Lee HY,Tae WS,Yoon HK,et al.Demonstration of decreased gray matter concentration in the midbrain encompassing the dorsal raphe nucleus and the limbic subcortical regions in major depressive disorder: an optimized voxel-based morphometry study.J Affect Disord. 2011;133:128-136.
25. Zhang J,Wang J,Wu Q,et al.Disrupted brain connectivity networks in drug-naive, first-episode major depressive disorder.Biol Psychiatry. 2011;70:334-342.
26. Ma N,Li L,Shu N,et al.White matter abnormalities in first-episode, treatment-naive young adults with major depressive disorder.Am J Psychiatry. 2007;164:823-826.
27. Wang L,Li K,Zhang QE,et al.Interhemispheric functional connectivity and its relationships with clinical characteristics in major depressive disorder: a resting state fMRI study.PloS One. 2013;8:e60191-e60191.
28. Veer IM,Beckmann CF,van Tol MJ,et al.Whole brain resting-state analysis reveals decreased functional connectivity in major depression.Front Syst Neurosci. 2010;4:41-41.
29. Yuan Y,Zhang Z,Bai F,et al.Abnormal neural activity in the patients with remitted geriatric depression: a resting-state functional magnetic resonance imaging study.J Affect Disord. 2008;111:145-152.
30. Maciag D,Hughes J,O'Dwyer G,et al.Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies.Biol Psychiatry. 2010;67:465-470.
31. Rajkowska G,O'Dwyer G,Teleki Z,et al.GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression.Neuropsychopharmacology. 2007;32:471-482.
32. Lui S,Li T,Deng W,et al.Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by "resting state" functional magnetic resonance imaging.Arch Gen Psychiatry. 2010;67:783-792.
33. Fitzgerald PB,Laird AR,Maller J,et al.A meta-analytic study of changes in brain activation in depression.Hum Brain Mapp. 2008;29:683-695.
34. Uher R,Tansey K,Rietschel M,et al.Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.Am J Psychiatry. 2013;170:207-217.
35. Bremner JD.Structural changes in the brain in depression and relationship to symptom recurrence.CNS Spectr. 2002;7:129 135-130 139.
36. Alalade E,Denny K,Potter G,et al.Altered cerebellar-cerebral functional connectivity in geriatric depression.PloS One. 2011;6:e20035-e20035.
37. Zeng LL,Shen H,Liu L,et al.Identifying major depression using whole-brain functional connectivity: a multivariate pattern analysis.Brain. 2012;135 (Pt 5): 1498-1507.
38. Chantiluke K,Halari R,Simic M,et al.Fronto-striato-cerebellar dysregulation in adolescents with depression during motivated attention.Biol Psychiatry. 2012;71:59-67.
39. Guo WB,Sun XL,Liu L,et al.Disrupted regional homogeneity in treatment-resistant depression: a resting-state fMRI study.Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:1297-1302.
40. Wu QZ,Li DM,Kuang WH,et al.Abnormal regional spontaneous neural activity in treatment-refractory depression revealed by resting-state fMRI.Hum Brain Mapp. 2011;32:1290-1299.
41. Liu Z,Xu C,Xu Y,et al.Decreased regional homogeneity in insula and cerebellum: a resting-state fMRI study in patients with major depression and subjects at high risk for major depression.Psychiatry Res. 2010;182:211-215.
42. Berton O,Nestler EJ.New approaches to antidepressant drug discovery: beyond monoamines.Nat Rev Neurosci. 2006;7:137-151.
43. Rajkowska G.Histopathology of the prefrontal cortex in major depression: what does it tell us about dysfunctional monoaminergic circuits?.Prog Brain Res. 2000;126:397-412.
44. Nandhu MS,Paul J,Kuruvila KP,et al.Glutamate and NMDA receptors activation leads to cerebellar dysfunction and impaired motor coordination in unilateral 6-hydroxydopamine lesioned Parkinson's rat: functional recovery with bone marrow cells, serotonin and GABA.Mol Cell Biochem. 2011;353:47-57.
45. Raichle ME,MacLeod AM,Snyder AZ,et al.A default mode of brain function.Proc Natl Acad Sci U S A. 2001;98:676-682.
46. Sambataro F,Wolf ND,Pennuto M,et al.Revisiting default mode network function in major depression: evidence for disrupted subsystem connectivity.Psychol Med. 2013;:1-11.